Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target

Molecular and Cellular Proteomics

Volumn 12, Issue 12, 2013, Pages 3778-3792

  Rasanen, Kati ^a   Sriswasdi, Sira ^a   Valiga, Alexander ^a   Tang, Hsin Yao ^a   Zhang, Gao ^a   Perego, Michela ^a   Somasundaram, Rajasekharan ^a   Li, Ling ^a   Speicher, Kaye ^a   Klein Szanto, Andres J ^b   Basu, Devraj ^a,c   Rustgi, Anil K ^d   Speicher, David W ^a   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; COLLAGEN; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TUMOR MARKER; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; GENE SILENCING; GENE TARGETING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; MESENCHYME CELL; METASTASIS; METASTASIS INHIBITION; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; RNA INTERFERENCE; SOLID TUMOR; ZYMOGRAPHY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; COLLAGEN; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASE 2; MICE; MOLECULAR SEQUENCE ANNOTATION; NEOPLASM TRANSPLANTATION; NF-KAPPA B; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; S100 PROTEINS; SIGNAL TRANSDUCTION;

EID: 84890774497     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.029587     Document Type: Article

References (54)

1. Masuda, M., Toh, S., Wakasaki, T., Suzui, M., and Joe, A. K. (2013) Somatic evolution of head and neck cancer - biological robustness and latent vulnerability. Mol. Oncol. 1, 14-28
2. Worsham, M. J., Ali, H., Dragovic, J., and Schweitzer, V. P. (2012) Molecular characterization of head and neck cancer: How close to personalized targeted therapy? Mol. Diagn. Ther. 16, 209-222
3. Basu, D., Nguyen, T. T., Montone, K. T., Zhang, G., Wang, L. P., Diehl, J. A., Rustgi, A. K., Lee, J. T., Weinstein, G. S., and Herlyn, M. (2010) Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity. Oncogene 29, 4170-4182
4. Basu, D., Montone, K. T., Wang, L., Gimotty, P. A., Hammond, R., Diehl, J. A., Rustgi, A. K., Lee, J. T., Rasanen, K., Weinstein, G. S., and Herlyn, M. (2011) Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas. Cell Cycle 10, 2008-2016
5. Kalluri, R., and Weinberg, R. A. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428
6. Scheel, C., Eaton, E. N., Li, S. H., Chaffer, C. L., Reinhardt, F., Kah, K. J., Bell, G., Guo, W., Rubin, J., Richardson, A. L., and Weinberg, R. A. (2011) Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 145, 926-940
7. Hanahan, D., and Coussens, L. M. (2012) Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell. 21, 309-322
8. Marsh, T., Pietras, K., and McAllister, S. S. (2013) Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 1832, 1070-1078
9. Rasanen, K., and Vaheri, A. (2010) Activation of fibroblasts in cancer stroma. Exp. Cell Res. 316, 2713-2722
10. Sugimoto, H., Mundel, T. M., Kieran, M. W., and Kalluri, R. (2006) Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer. Biol. Ther. 5, 1640-1646
11. Sherbet, G. V. (2009) Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett. 280, 15-30
12. Saleem, M., Kweon, M. H., Johnson, J. J., Adhami, V. M., Elcheva, I., Khan, N., Bin Hafeez, B., Bhat, K. M., Sarfaraz, S., Reagan-Shaw, S., Spiegelman, V. S., Setaluri, V., and Mukhtar, H. (2006) S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc. Natl. Acad. Sci. U.S.A. 103, 14825-14830
13. Olsen, C. J., Moreira, J., Lukanidin, E. M., and Ambartsumian, N. S. (2010) Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer 10, 444-2407-10-444
14. Andersen, K., Mori, H., Fata, J., Bascom, J., Oyjord, T., Maelandsmo, G. M., and Bissell, M. (2011) The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis. Dev. Biol. 352, 181-190
15. Donato, R., Cannon, B. R., Sorci, G., Riuzzi, F., Hsu, K., Weber, D. J., and Geczy, C. L. (2013) Functions of S100 proteins. Curr. Mol. Med. 13, 24-57
16. Noma, K., Smalley, K. S., Lioni, M., Naomoto, Y., Tanaka, N., El-Deiry, W., King, A. J., Nakagawa, H., and Herlyn, M. (2008) The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 134, 1981-1993
17. Räsänen, K., Virtanen, I., Salmenperä, P., Grenman, R., and Vaheri, A. (2009) Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinoma. PLoS One 4, e6879
18. Rasanen, K., and Vaheri, A. (2010) TGF-beta1 causes epithelial- mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes. J. Dermatol. Sci. 58, 97-104
19. Li, L., Fukunaga-Kalabis, M., and Herlyn, M. (2011) The three-dimensional human skin reconstruct model: A tool to study normal skin and melanoma progression. J. Vis. Exp. 54, pii: 2937. doi, 10.3791/2937
20. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 26, 1367-1372
21. Wang, H., Tang, H. Y., Tan, G. C., and Speicher, D. W. (2011) Data analysis strategy for maximizing high-confidence protein identifications in complex proteomes such as human tumor secretomes and human serum. J. Proteome Res. 10, 4993-5005
22. Tang, H. Y., Beer, L. A., Barnhart, K. T., and Speicher, D. W. (2011) Rapid verification of candidate serological biomarkers using gel-based, labelfree multiple reaction monitoring. J. Proteome Res. 10, 4005-4017
23. Beer, L. A., Tang, H. Y., Sriswasdi, S., Barnhart, K. T., and Speicher, D. W. (2011) Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation. J. Proteome Res. 10, 1126-1138
24. Tang, H. Y., Beer, L. A., Chang-Wong, T., Hammond, R., Gimotty, P., Coukos, G., and Speicher, D. W. (2012) A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer. J. Proteome Res. 11, 678-691
25. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
26. Pfaffl, M. W., Horgan, G. W., and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36
27. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
28. Kendal, W. S. (2007) Empirically-based estimates for the burden of subclinical metastases. Int. J. Radiat. Biol. 83, 383-393
29. Tsellou, E., and Kiaris, H. (2008) Fibroblast independency in tumors: Implications in cancer therapy. Future Oncol. 4, 427-432
30. Friedl, P., and Wolf, K. (2010) Plasticity of cell migration: A multiscale tuning model. J. Cell Biol. 188, 11-19
31. Dvorak, H. F. (1986) Tumors: Wounds that do not heal. similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659
32. Grunert, S., Jechlinger, M., and Beug, H. (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4, 657-665
33. Polyak, K., and Weinberg, R. A. (2009); 2009) Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273
34. Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Dobbeling, U., Kobert, N., Schaerer, L., Hemmi, S., and Dummer, R. (2008) In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650-656
35. Widmer, D. S., Cheng, P. F., Eichhoff, O. M., Belloni, B. C., Zipser, M. C., Schlegel, N. C., Javelaud, D., Mauviel, A., Dummer, R., and Hoek, K. S. (2012) Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res. 25, 343-353
36. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: The next generation. Cell 144, 646-674
37. Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., and Sahai, E. (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat. Cell Biol. 9, 1392-1400
38. Gelse, K., Poschl, E., and Aigner, T. (2003) Collagens - structure, function, and biosynthesis. Adv. Drug Deliv. Rev. 55, 1531-1546
39. Powell, A. M., Sakuma-Oyama, Y., Oyama, N., and Black, M. M. (2005) Collagen 17/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex. Clin. Exp. Dermatol. 30, 682-687
40. Singh, A., and Settleman, J. (2010) EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene 29, 4741-4751
41. Chen, C., Zimmermann, M., Tinhofer, I., Kaufmann, A. M., and Albers, A. E. (2013) Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer Lett. 338, 47-56
42. Lo, J. F., Yu, C. C., Chiou, S. H., Huang, C. Y., Jan, C. I., Lin, S. C., Liu, C. J., Hu, W. Y., and Yu, Y. H. (2011) The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res. 71, 1912-1923
43. Sack, U., Walther, W., Scudiero, D., Selby, M., Kobelt, D., Lemm, M., Fichtner, I., Schlag, P. M., Shoemaker, R. H., and Stein, U. (2011) Novel effect of antihelminthic niclosamide on S100A4-mediated metastatic progression in colon cancer. J. Natl. Cancer Inst. 103, 1018-1036
44. Li, N., Song, M. M., Chen, X. H., Liu, L. H., and Li, F. S. (2012) S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro. Biomed. Environ. Sci. 25, 465-470
45. Zhang, H. Y., Zheng, X. Z., Wang, X. H., Xuan, X. Y., Wang, F., and Li, S. S. (2012) 100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity. Mol. Biol. Rep. 39, 199-208
46. Cohen, A., Wang, E., Chisholm, K. A., Kostyleva, R., O'Connor-McCourt, M., and Pinto, D. M. (2013) A mass spectrometry-based plasma protein panel targeting the tumor microenvironment in patients with breast cancer. J. Proteomics 81, 135-147
47. Chen, D., Zheng, X. F., Yang, Z. Y., Liu, D. X., Zhang, G. Y., Jiao, X. L., and Zhao, H. (2012) S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells. World J. Gastroenterol. 18, 915-922
48. Sekine, H., Chen, N., Sato, K., Saiki, Y., Yoshino, Y., Umetsu, Y., Jin, G., Nagase, H., Gu, Z., Fukushige, S., Sunamura, M., and Horii, A. (2012) S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 429, 214-219
49. Cruz, F. D., and Matushansky, I. (2012) Solid tumor differentiation therapy. Oncotarget 3, 559-567
50. Azzi, S., Bruno, S., Giron-Michel, J., Clay, D., Devocelle, A., Croce, M., Ferrini, S., Chouaib, S., Vazquez, A., Charpentier, B., Camussi, G., Azzarone, B., and Eid, P. (2011) Differentiation therapy: Targeting human renal cancer stem cells with interleukin 15. J. Natl. Cancer Inst. 103, 1884-1898
51. Davidson, B. L., and McCray, P. B. Jr. (2011) Current prospects for RNA interference- based therapies. Nat. Rev. Genet. 12, 329-340
52. Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., and Ribas, A. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nat. Lett. 464, 1067-1071
53. Daniels, T. R., Bernabeu, E., Rodriguez, J. A., Patel, S., Kozman, M., Chiappetta D. A., Holler, E., Ljubimova, J. Y., Helguera, G., and Penichet, M. L. (2012) Tranferrin receptors and the targeted delivery of therapeutic agenst against cancer. Biochim. Biophys. Acta 1820, 291-317
54. Gross, S. R., Sin, C. G., Barraclough, R., and Rudland, P. S. (2013) Joining S100 proteins and migration: for better or worse, in sickness and in health. Cell Mol. Life Sci. In press